Sessioni Poster

PAIN PHARMACOLOGY

26/10/2017 / 19.00 - 21.00
138Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain Injury
1)Belardo C. 2)Guida F. 3)Boccella S. 4)Iannotta M. 5)De gregorio D. 6)Giordano C. 7)Romano R. 8)Pòalazzo E. 9)Scafuro MA. 10)Serra N. 11)De novellis V. 12)Rossi F. 13)Maione S. 14)Luongo L.
143PALMITOYLETHANOLAMIDE, VIA PPAR-ALPHA RECEPTOR, RESTORES THE ALTERED SYNAPTIC PLASTICITY AND AMELIORATES THE COMPROMISED PAIN-RELATED BEHAVIOURS IN THE HIPPOCAMPUS IN NEUROPATHIC MICE.
1)Boccella S.. 2)Luongo L.. 3)Guida F.. 4)Belardo C.. 5)Iannotta M.. 6)Mazzitelli M.. 7)De gregorio D.. 8)Romano R.. 9)Marabese I.. 10)Palazzo E.. 11)De novellis V.. 12)Maione S..
148ACTIVATION OF PPAR_ AS A NEW PHARMACOLOGICAL STRATEGY TO TREAT NEUROPATHIC PAIN
1)Borruto AM. 2)Brunori G. 3)Benvenuti F. 4)Ubaldi M. 5)Ciccocioppo R.
222PHARMACOLOGICAL EFFECT OF PERAMPANEL, A NEW AMPA ANTAGONIST, IN ANIMAL MODELS OF ACUTE AND CHRONIC PAIN.
1)De Caro C. 2)Russo E. 3)Citraro R. 4)Russo R. 5)Leo A. 6)Leporini C. 7)Avagliano C. 8)Cristiano C. 9)La Rana G. 10)Aiello E. 11)Santangelo E. 12)Calignano A. 13)De Sarro GB.
225Aromatase inhibitor-evoked pain is promoted by the enzyme substrate, androstenedione, via transient receptor potential ankyrin 1 (TRPA1) in mice 
1)De logu FD. 2)Tonello RT. 3)Nassini RN. 4)Fusi CF. 5)Coppi EC. 6)Li puma SL. 7)Marone IM. 8)Sadofsky LS. 9)Morice AM. 10)Susini TS. 11)Terreni AT. 12)Di tommaso MD. 13)Geppetti PG. 14)Benemei SB.
241Isoform-selective blockade of HCN channels in dorsal root ganglion neurons as a potential pharmacological strategy against pain
Dini L. M. Del Lungo1, F. Resta1,2, M. Melchiorre1,3, V. Spinelli1, A. Laurino1, L. Sartiani1, A. Mugelli1, G. Mannaioni1, E. Cerbai1, and MN. Romanelli1.
299D-ASPARTIC ACID AMELIORATES COGNITIVE IMPAIRMENT IN A MOUSE MODEL OF SPARED NERVE INJURY AND REDUCES _-AMYLOID A_1-40 AND A_1-42 PEPTIDES
1)Iannotta M.. 2)Rosaria R.. 3)Belardo C.. 4)D'aniello A.. 5)Luongo L.. 6)De novellis V.. 7)Maione S..
301THE ROLE OF SIRT3 PATHWAY IN NEUROPATHIC PAIN AND OXIDATIVE STRESS
1)Ilari S. 2)Giancotti LA. 3)Lauro F. 4)Morabito C. 5)Malafoglia V. 6)Gliozzi M. 7)Tafani M. 8)Fini M. 9)Russo M. 10)Mollace V. 11)Salvemini D. 12)Muscoli C.
312The antimigraine butterbur ingredient, isopetasin, desensitizes peptidergic nociceptors via the transient receptor potential ankyrin 1 channel.
1)Li puma S.. 2)Benemei S.. 3)De logu F.. 4)Marone I.. 5)Coppi E.. 6)Ugolini F.. 7)Liedtke W.. 8)Pollastro F.. 9)Appendino G.. 10)Geppetti P.. 11)Materazzi S.. 12)Nassini R..
317Alteration of visceral sensitivity after induction of colitis in rats: focus on the role of tryptophan in the development of abdominal pain
1)Lucarini E. 2)Di cesare mannelli L. 3)Micheli L. 4)Maresca M. 5)Tenci B. 6)Trallori E. 7)Awada K. 8)Cozzi A. 9)Milla M. 10)Fornai M. 11)Antonioli L. 12)Blandizzi C. 13)Ghelardini C.
335Into the unexplored pathophysiological role of the blood brain barrier during oxaliplatin-induced neuropathy
1)Maresca M. 2)Di cesare mannelli L. 3)Branca J. 4)Micheli L. 5)Tenci B. 6)Lucarini E. 7)Trallori E. 8)Awada K. 9)Morucci G. 10)De bock M. 11)Leybaert L. 12)Pacini A. 13)Gulisano M. 14)Ghelardini C.
346A PRECLINICAL SET UP OF A RAT MODEL OF FOLFOX-INDUCED NEUROPATHY: EFFECT OF DIMIRACETAM
1)Micheli L. 2)Di cesare mannelli L. 3)Maresca M. 4)Lucarini E. 5)Tenci B. 6)Trallori E. 7)Awada K. 8)Farina C. 9)Scherz MW. 10)Ghelardini C.
353ROLE OF PROKINETICIN SYSTEM IN A MURINE MODEL OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY.
1)Moschetti G.. 2)Amodeo G.. 3)Lattanzi R.. 4)Sacerdote P..
429Development of an in vitro model to test new putative Pannexin-1 inhibitors against neuropathic pain.
1)Trallori E. 2)Di Cesare Mannelli L. 3)Maresca M. 4)Tenci B. 5)Lucarini E. 6)Micheli L. 7)Awada K. 8)Crocetti L. 9)Giovannoni MP. 10)Ghelardini C.
445CHEMOTHERAPY-INDUCED NEUROPATHIC PAIN: P2X7 RECEPTOR AND RECRUITMENT OF PANNEXIN1
1)Venturini A. 2)Marcoli M. 3)Di cesare mannelli L. 4)Cervetto C. 5)Tenci B. 6)Micheli L. 7)Maura G. 8)Ghelardini C.
447ANTI-NOCICEPTIVE EFFECTS OF NOVEL HIGHLY POTENT A2A ADENOSINE RECEPTOR INVERSE AGONISTS
1)Vincenzi F. 2)Varano F. 3)Ravani A. 4)Pasquini S. 5)Merighi S. 6)Gessi S. 7)Catarzi D. 8)Colotta V. 9)Borea PA. 10)Varani K.